|
End-of-day quote
Korea S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 4,705.00 KRW | +11.49% |
|
-13.99% | -31.61% |
| Sep. 20 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| Aug. 14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +11.49% | -13.99% | +38.59% | +29.79% | -31.61% | +77.88% | -25.79% | -73.97% | - | 185M | |
| -6.60% | -8.56% | -9.81% | +22.40% | +59.20% | +49.38% | +64.90% | +0.42% | - | 65B | |
| +0.03% | +5.56% | +10.70% | +6.38% | +12.31% | +9.10% | +75.22% | -16.57% | +227.73% | 51.2B | |
| -4.09% | -0.11% | -16.50% | -3.24% | +1.51% | +2.22% | +55.67% | +187.36% | +4,829.54% | 51.19B | |
| -1.53% | +2.70% | +0.18% | +29.40% | +18.41% | +30.48% | +41.25% | +7.42% | +249.67% | 43.93B | |
| -1.34% | +4.12% | +5.19% | +18.28% | +21.48% | +16.64% | +120.28% | +2.29% | +1,022.10% | 41.96B | |
| -5.97% | -6.22% | -6.80% | -4.40% | +123.43% | +228.95% | +483.48% | +535.57% | - | 38.14B | |
| +6.53% | +8.02% | +8.14% | +10.35% | +12.54% | +16.40% | +56.32% | +8.99% | +158.01% | 33.24B | |
| -0.90% | -10.49% | -4.27% | +30.34% | +53.31% | +37.09% | +1.80% | -58.05% | - | 25.2B | |
| -1.07% | +2.33% | +10.71% | +33.87% | +23.43% | +19.43% | +20.40% | -12.27% | +120.05% | 22.5B | |
| -2.76% | -9.54% | -8.69% | -4.12% | -7.87% | -16.58% | -7.07% | -66.41% | - | 22.03B | |
| -2.96% | -4.30% | -19.77% | -11.12% | -44.69% | -41.92% | +280.81% | +265.21% | +601.68% | 21.02B | |
| -1.61% | +1.05% | +1.00% | +15.01% | +10.12% | +17.12% | +167.71% | +232.83% | +1,914.56% | 17.26B | |
| +3.32% | +4.18% | +5.51% | +4.18% | +193.84% | +167.65% | +402.49% | +1,518.37% | +798.88% | 15.9B | |
| -0.95% | +3.96% | +6.63% | +11.28% | +41.98% | +58.55% | +191.48% | +192.02% | +433.25% | 15.42B | |
| -1.14% | +1.48% | +2.38% | +11.35% | +25.42% | +25.18% | +60.07% | -28.67% | +86.62% | 15.28B | |
| -0.60% | -1.74% | -4.85% | -13.70% | - | - | - | - | - | 14.79B | |
| -1.99% | -0.54% | +7.94% | +33.79% | +50.47% | +68.13% | +62.10% | -27.50% | +270.19% | 14.33B | |
| +3.10% | +1.66% | -2.08% | -7.07% | +15.25% | -1.40% | +496.31% | - | - | 13.77B | |
| -2.83% | +3.66% | +3.70% | +0.11% | -6.61% | -8.04% | -24.91% | -38.47% | +115.58% | 13.13B | |
| Average | -0.59% | -0.57% | +1.39% | +10.64% | +30.10% | +39.80% | +132.76% | +146.03% | +832.91% | 26.77B | |
| Weighted average by Cap. | -1.83% | -0.50% | -1.60% | +11.05% | +33.19% | +39.07% | +124.64% | +122.44% | +1,101.34% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
